181
Views
34
CrossRef citations to date
0
Altmetric
Original Research

Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models

, , , , , , , & show all
Pages 4847-4867 | Published online: 29 Aug 2018

References

  • SenkusEKyriakidesSPenault-LlorcaFESMO Guidelines Working GroupPrimary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnn Oncol201324suppl 6vi7vi2323970019
  • RiveraECianfroccaMOverview of neuropathy associated with taxanes for the treatment of metastatic breast cancerCancer Chemother Pharmacol201575465967025596818
  • HolmesFAWaltersRSTheriaultRLPhase II trial of taxol, an active drug in the treatment of metastatic breast cancerJ Natl Cancer Inst19918324179718051683908
  • MengZLvQLuJProdrug strategies for paclitaxelInt J Mol Sci2016175E79627223283
  • AftabSShahANadhmanANanomedicine: an effective tool in cancer therapyInt J Pharm20185401–213214929427746
  • CavallaroGSardoCCraparoEFPorsioBGiammonaGPolymeric nanoparticles for siRNA delivery: production and applicationsInt J Pharm2017525531333328416401
  • WangKHuangQQiuFSuiMNon-viral delivery systems for the application in p53 cancer gene therapyCurr Med Chem201522354118413626423086
  • WangFLiCChengJYuanZRecent advances on inorganic nanoparticle-based cancer therapeutic agentsInt J Environ Res Public Health201613121182
  • ZhangBWangKSiJSuiMShenYCharge-reversal polymers for biodeliveryGuZBioinspired and Biomimetic Polymer Systems for Drug and Gene DeliveryWeinheim, GermanyWiley-VCH Verlag GmbH & Co. KGaA2014223242
  • GagliardiMSilvestriDCristalliniCMacromolecular composition and drug-loading effect on the delivery of paclitaxel and folic acid from acrylic matricesDrug Deliv201017645246520504107
  • LohcharoenkalWWangLChenYCRojanasakulYProtein nanoparticles as drug delivery carriers for cancer therapyBiomed Res Int20142014112
  • DosioFBrusaPCrosassoPArpiccoSCattelLPreparation, characterization and properties in vitro and in vivo of a paclitaxel–albumin conjugateJ Control Release199747293304
  • FanciullinoRCiccoliniJMilanoGChallenges, expectations and limits for nanoparticles-based therapeutics in cancer: a focus on nano-albumin-bound drugsCrit Rev Oncol Hematol201388350451323871532
  • MaPMumperRJPaclitaxel nano-delivery systems: a comprehensive reviewJ Nanomed Nanotechnol201342100016424163786
  • AluigiASotgiuGFerroniCChlorin e6 keratin nanoparticles for photodynamic anticancer therapyRSC Adv201663391033918
  • ZhiXWangYLiPYuanJShenJPreparation of keratin/chlorhexidine complex nanoparticles for long-term and dual stimuli-responsive releaseRSC Adv201558233482341
  • YuBTaiHCXueWLeeLJLeeRJReceptor-targeted nanocarriers for therapeutic delivery to cancerMol Membr Biol201027728629821028937
  • XuHShiZReddyNYangYIntrinsically water-stable keratin nanoparticles and their in vivo biodistribution for targeted deliveryJ Agric Food Chem201462379145915025174826
  • LiQZhuLLiuRBiological stimuli responsive drug carriers based on keratin for triggerable drug deliveryJ Mater Chem201222371996419973
  • LiYZhiXLinJYouXYuanJPreparation and characterization of DOX loaded keratin nanoparticles for pH/GSH dual responsive releaseMater Sci Eng C201773189197
  • KunjiappanSChowdhuryASomasundaramBBhattacharjeeCOptimization, preparation and characterization of rutinquercetin dual drug loaded keratin nanoparticles for biological applicationsNanomed J20163253267
  • ChenQLiangCWangCLiuZAn imagable and photothermal “Abraxane-like” nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumorsAdv Mater201527590391025504416
  • CukiermanEPankovRStevensDRYamadaKMTaking cell-matrix adhesions to the third dimensionScience200129455471708171211721053
  • PampaloniFReynaudEGStelzerEHKThe third dimension bridges the gap between cell culture and live tissueNat Rev Mol Cell Biol200781083984517684528
  • HirtCPapadimitropoulosAMeleV“In vitro” 3D models of tumor-immune system interactionAdv Drug Deliv Rev201479–80145154
  • HirtCPapadimitropoulosAMuraroMGBioreactor-engineered cancer tissue-like structures mimic phenotypes, gene expression profiles and drug resistance patterns observed “in vivo”Biomaterials20156213814626051518
  • DästerSAmatrudaNCalabreseDInduction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatmentOncotarget20168117251736
  • WendtDStroebelSJakobMJohnGTMartinIUniform tissues engineered by seeding and culturing cells in 3D scaffolds under perfusion at defined oxygen tensionsBiorheology2006433,448148816912419
  • WendtDMarsanoAJakobMHebererMMartinIOscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformityBiotechnol Bioeng200384220521412966577
  • LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT methodMethods200125440240811846609
  • GongGXuYZhouYMolecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo imageBiomacromolecules2012131232822029860
  • MotlaghNSHParvinPGhasemiFAtyabiFFluorescence properties of several chemotherapy drugs: doxorubicin, paclitaxel and bleomycinBiomed Opt Express2016762400240627375954
  • ZhouH-BZhuJ-RPaclitaxel induces apoptosis in human gastric carcinoma cellsWorld J Gastroenterol20039344244512632493
  • WangJHeFTzangCDifferential gene expression profiles in paclitaxel-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cellsYao Xue Xue Bao2005401099110416496673
  • SaundersDELawrenceWDChristensenCWapplerNLRuanHDeppeGPaclitaxel-induced apoptosis in MCF-7 breast-cancer cellsInt J Cancer19977022142209009163
  • GuptaNLiuJRPatelBSolomonDEVaidyaBGuptaVMicrofluidics- based 3D cell culture models: utility in novel drug discovery and delivery researchBioeng Transl Med201611638129313007
  • TaherianALiXLiuYHaasTADifferences in integrin expression and signaling within human breast cancer cellsBMC Cancer20111129321752268
  • McIlwainDRBergerTMakTWCaspase functions in cell death and diseaseCold Spring Harb Perspect Biol201354a00865623545416
  • GradisharWJTjulandinSDavidsonNPhase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil–based paclitaxel in women with breast cancerJ Clin Oncol200523317794780316172456
  • DesaiNPTaoCYangA webpage on the InternetProtein Stabilized Pharmacologically Active Agents, Methods for the Preparation Thereof and Methods for the Use Thereof2004 Available from: https://www.google.com/patents/US6749868Accessed June 15, 2004
  • DesaiNPSoon-ShiongP webpage on the InternetPaclitaxel-Containing Formulations2004 Available from: https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040622&DB=&locale=&CC=US&NR=6753006B1&KC=B1&ND=1Accessed June 15, 2018
  • ZhaoSWangWHuangYFuYChengYPaclitaxel loaded human serum albumin nanoparticles stabilized with intermolecular disulfide bondsMed Chem Commun201451116581663
  • Ajay SharmaLAliMALoveRMWilsonMJDiasGJNovel keratin preparation supports growth and differentiation of odontoblast-like cellsInt Endod J201649547148226016886
  • VermaVVermaPRayPRayARPreparation of scaffolds from human hair proteins for tissue-engineering applicationsBiomed Mater20083202500718458372
  • DesgrosellierJSChereshDAIntegrins in cancer: biological implications and therapeutic opportunitiesNat Rev Cancer201010192220029421
  • ZhangFHuangXZhuLNoninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticlesBiomaterials201233215414542222560667
  • JuJAGodetIYeICHypoxia selectively enhances integrin α 5 β 1 receptor expression in breast cancer to promote metastasisMol Cancer Res201715672373428213554
  • DuchiSDambruosoPMartellaEThiophene-based compounds as fluorescent tags to study mesenchymal stem cell uptake and release of taxanesBioconjug Chem201425464965524628247
  • ImamuraYMukoharaTShimonoYComparison of 2D- and 3D-culture models as drug-testing platforms in breast cancerOncol Rep20153341837184325634491
  • XuXFarach-CarsonMCJiaXThree-dimensional in vitro tumor models for cancer research and drug evaluationBiotechnol Adv20143271256126825116894
  • FongELSLamhamedi-CherradiS-EBurdettEModeling Ewing sarcoma tumors in vitro with 3D scaffoldsProc Natl Acad Sci U S A2013110166500650523576741
  • WeigeltBLoATParkCCGrayJWBissellMJHER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironmentBreast Cancer Res Treat20101221354319701706
  • BurdettEKasperFKMikosAGLudwigJAEngineering tumors: a tissue engineering perspective in cancer biologyTissue Eng Part B Rev201016335135920092396
  • MuranenTSelforsLMWorsterDTInhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cellsCancer Cell201221222723922340595
  • HuangCParkCCHilsenbeckSGβ1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinibBreast Cancer Res2011134R8421884573